(thirdQuint)Efficacy of Novel Drug-combinations for Relief of Psoriasis.

 In this prospective, observational study, change in psoriasis plaque appearance, per the Psoriasis Area Severity Index (PASI) tool, will be evaluated after using a topical psoriasis cream containing at least 3 of the following: corticosteroid, methotrexate, vitamin D3 or synthetic analog, retinoid acid, or urea, or a topical shampoo or spray containing a corticosteroid and vitamin D3 or synthetic analog.

 The change in quality of life will be assessed during all visits using the Skindex-16 assessment tool.

 In patients receiving a methotrexate-containing formulation, a sub-study will be available as an option, where laboratory values (methotrexate levels, complete blood count, liver function tests, etc.

) will be obtained to confirm that methotrexate absorption is negligible.

.

 Efficacy of Novel Drug-combinations for Relief of Psoriasis@highlight

ENDURE is a prospective, observational study aimed to document clinical response and side effects associated with compounded psoriasis medications when prescribed as routine care.

 As a secondary initiative, this study will assess methotrexate systemic absorption and toxicity in patients prescribed a methotrexate-containing compounded formulation.

